Interview with Kitima Yuthavong, CEO, PREMA Thailand
PReMa was established in 2004 after a period of transformation to represent the growing role of its members, research-based companies. To begin with, could you explain us the main milestones…
Address: 408/85, 19th Floor, Phaholyothin Place Bldg. Phaholyothin Road Samsennai, Phayathai Bangkok 10400,Thailand
Tel: (02) 619-0232
PREMA is a non-profit organization representing members who are research based pharmaceutical companies innovating medicines to combat the previously incurable diseases and to improve on existing treatments.
The Pharmaceutical Research and Manufacturers Association (PReMA) is dedicated to promoting good health and quality of life for the Thai people and to support the advancement of public health systems through the research and development of innovative medicines. PReMA also supports the rights to choice by the people and the healthcare professionals to high quality medicines that best meet their needs.
PReMa was established in 2004 after a period of transformation to represent the growing role of its members, research-based companies. To begin with, could you explain us the main milestones…
Thailand boasts one of the most attractive business and investment environments in the ASEAN region, and pharmaceutical companies implanted in the country benefit from a highly-skilled workforce and enabling infrastructure.…
Thailand is becoming an increasingly attractive location for pharma companies to conduct clinical trials, with multinationals such as Novo Nordisk and Boehringer Ingelheim conducting more and more of their global…
Diabetes affects more than eight percent of the Thai population, a number that is on the rise, and nearly half of these cases remain undiagnosed. In light of this epidemic,…
Dr Kumthorn Malathum, president of the Infectious Disease Association of Thailand, shares his insight on the issue of infectious disease in the country and the need to develop collaboration in…
Karri Kivela, executive director of the European Association for Business and Commerce (EABC) in Thailand outlines the organization’s mains activities, the ease of doing business for European companies in Thailand,…
Dr Armin Wiesler, general manager and head of Human Pharma at Boehringer Ingelheim (Thai) Ltd., explores how the affiliate has managed to achieve market-leading growth rates and addressed the challenges…
Under Thailand’s Universal Coverage Scheme, Thai citizens at every stage of life are entitled to essential health services and 99% of its population are currently covered. This year, not resting…
As the general manager of Menarini Thailand, Thomas Scott Birsinger shares the importance of the Thai affiliate within the company’s operations in the region. He also describes its efforts to…
Brijesh Sawlani, general manager for North ASEAN Thailand, Myanmar and Indochina at bioMérieux, discusses current opportunities for the Thai affiliate, the competitive landscape in Thailand, his key strategic objective to…
Dr Jadej Thammatacharee, deputy secretary general of the Thai National Health Security Office (NHSO), outlines the evolution of Thailand’s universal healthcare coverage program, the challenges inherent in its implementation, and…
Sukanya Uerchuchai, executive director of the Franco-Thai Chamber of Commerce, introduces one of the most dynamic European Chambers in Thailand, highlights the trade between Thailand and France, and explains the…
John Dawber, vice president and general manager of Novo Nordisk Thailand, offers his first impressions of the Thai market since moving from Japan. Dawber explains the current challenges and areas…
See our Cookie Privacy Policy Here